These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2974532)
1. Fluorescent cytometric analysis of polymorphonuclear leukocytes in Chediak-Higashi syndrome: diminished C3bi receptor expression (OKM1) with normal granular cell density. Cairo MS; Vandeven C; Toy C; Tischler D; Sender L Pediatr Res; 1988 Dec; 24(6):673-6. PubMed ID: 2974532 [TBL] [Abstract][Full Text] [Related]
2. The Chédiak-Higashi syndrome. Evidence that defective leukotaxis is primarily due to an impediment by giant granules. Clawson CC; White JG; Repine JE Am J Pathol; 1978 Sep; 92(3):745-53. PubMed ID: 686156 [TBL] [Abstract][Full Text] [Related]
3. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. Zimmerli W; Seligmann B; Gallin JI J Clin Invest; 1986 Mar; 77(3):925-33. PubMed ID: 3005369 [TBL] [Abstract][Full Text] [Related]
4. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186 [TBL] [Abstract][Full Text] [Related]
5. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. Berger M; O'Shea J; Cross AS; Folks TM; Chused TM; Brown EJ; Frank MM J Clin Invest; 1984 Nov; 74(5):1566-71. PubMed ID: 6209300 [TBL] [Abstract][Full Text] [Related]
6. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. Ganz T; Metcalf JA; Gallin JI; Boxer LA; Lehrer RI J Clin Invest; 1988 Aug; 82(2):552-6. PubMed ID: 2841356 [TBL] [Abstract][Full Text] [Related]
7. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes. Root RK; Rosenthal AS; Balestra DJ J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956 [TBL] [Abstract][Full Text] [Related]
8. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors. Graham IL; Gresham HD; Brown EJ J Immunol; 1989 Apr; 142(7):2352-8. PubMed ID: 2538507 [TBL] [Abstract][Full Text] [Related]
9. Impaired microtubule assembly and polymorphonuclear leucocyte function in the Chediak-Higashi syndrome correctable by ascorbic acid. Boxer LA; Albertini DF; Baehner RL; Oliver JM Br J Haematol; 1979 Oct; 43(2):207-13. PubMed ID: 508630 [TBL] [Abstract][Full Text] [Related]
10. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. Zhao H; Boissy YL; Abdel-Malek Z; King RA; Nordlund JJ; Boissy RE Lab Invest; 1994 Jul; 71(1):25-34. PubMed ID: 8041115 [TBL] [Abstract][Full Text] [Related]
11. The Chediak-Higashi syndrome: quantitation of a deficiency in maximal bactericidal capacity. Clawson CC; Repine JE; White JG Am J Pathol; 1979 Mar; 94(3):539-47. PubMed ID: 106731 [TBL] [Abstract][Full Text] [Related]
12. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes. Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247 [TBL] [Abstract][Full Text] [Related]
13. Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. Boxer LA; Watanabe AM; Rister M; Besch HR; Allen J; Baehner RL N Engl J Med; 1976 Nov; 295(19):1041-5. PubMed ID: 184391 [TBL] [Abstract][Full Text] [Related]
14. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. Baetz K; Isaaz S; Griffiths GM J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome. Liang JS; Lu MY; Tsai MJ; Lin DT; Lin KH J Formos Med Assoc; 2000 Jun; 99(6):499-502. PubMed ID: 10925557 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of high-dose intravenous gammaglobulin on the accelerated phase of Chediak-Higashi syndrome. Kinugawa N; Ohtani T Helv Paediatr Acta; 1985 Jul; 40(2-3):169-72. PubMed ID: 3843247 [TBL] [Abstract][Full Text] [Related]
17. The "lazy" NK cells of Chediak-Higashi syndrome. Targan SR; Oseas R J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174 [TBL] [Abstract][Full Text] [Related]
18. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release. Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603 [TBL] [Abstract][Full Text] [Related]
19. The Chédiak-Higashi syndrome; the nature of the giant neutrophil granules and their interactions with cytoplasm and foreign particulates. I. Progressive enlargement of the massive inclusions in mature neutrophils. II. Manifestations of cytoplasmic injury and sequestration. III. Interactions between giant organelles and foreign particulates. White JG; Clawson CC Am J Pathol; 1980 Jan; 98(1):151-96. PubMed ID: 6243205 [TBL] [Abstract][Full Text] [Related]
20. Clinico-hematological profile of Chediak-Higashi syndrome: experience from a tertiary care center in south India. Roy A; Kar R; Basu D; Srivani S; Badhe BA Indian J Pathol Microbiol; 2011; 54(3):547-51. PubMed ID: 21934218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]